La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Astrana Health Croissance future
Future contrôle des critères 3/6
Astrana Health devrait augmenter ses bénéfices et ses revenus de 18.7% et de 16% par an respectivement, tandis que le BPA devrait croître de croître de 16.9% par an.
Informations clés
18.7%
Taux de croissance des bénéfices
16.9%
Taux de croissance du BPA
| Healthcare croissance des bén éfices | 19.4% |
| Taux de croissance des recettes | 16.0% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Good |
| Dernière mise à jour | 15 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Aug 04Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 17Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 2,717 | 97 | N/A | 147 | 4 |
| 12/31/2025 | 2,251 | 80 | 106 | 117 | 8 |
| 12/31/2024 | 1,818 | 63 | 78 | 98 | 7 |
| 6/30/2024 | 1,592 | 68 | 50 | 64 | N/A |
| 3/31/2024 | 1,454 | 62 | 52 | 66 | N/A |
| 12/31/2023 | 1,387 | 61 | 40 | 68 | N/A |
| 9/30/2023 | 1,328 | 45 | 112 | 134 | N/A |
| 6/30/2023 | 1,297 | 46 | 61 | 83 | N/A |
| 3/31/2023 | 1,218 | 45 | 46 | 66 | N/A |
| 12/31/2022 | 1,144 | 45 | 59 | 82 | N/A |
| 9/30/2022 | 1,045 | 58 | -40 | -15 | N/A |
| 6/30/2022 | 955 | 69 | 41 | 72 | N/A |
| 3/31/2022 | 861 | 70 | 48 | 84 | N/A |
| 12/31/2021 | 774 | 69 | 51 | 70 | N/A |
| 9/30/2021 | 756 | 70 | 63 | 80 | N/A |
| 6/30/2021 | 709 | 53 | 57 | 65 | N/A |
| 3/31/2021 | 698 | 47 | 64 | 65 | N/A |
| 12/31/2020 | 687 | 38 | 45 | 46 | N/A |
| 9/30/2020 | 689 | 35 | 52 | 52 | N/A |
| 6/30/2020 | 665 | 22 | 47 | 48 | N/A |
| 3/31/2020 | 630 | 18 | 7 | 8 | N/A |
| 12/31/2019 | 561 | 14 | 13 | 14 | N/A |
| 9/30/2019 | 488 | 4 | 3 | 4 | N/A |
| 6/30/2019 | 499 | 10 | -11 | -10 | N/A |
| 3/31/2019 | 492 | 9 | 16 | 17 | N/A |
| 12/31/2018 | 520 | 11 | 24 | 25 | N/A |
| 9/30/2018 | 506 | 28 | 46 | 47 | N/A |
| 6/30/2018 | 436 | 24 | 39 | 41 | N/A |
| 3/31/2018 | 395 | 24 | N/A | 35 | N/A |
| 12/31/2017 | 356 | 26 | N/A | 52 | N/A |
| 9/30/2017 | 336 | 13 | N/A | 44 | N/A |
| 6/30/2017 | 323 | 11 | N/A | 45 | N/A |
| 3/31/2017 | 317 | 12 | N/A | 47 | N/A |
| 12/31/2016 | 306 | 11 | N/A | 22 | N/A |
| 12/31/2015 | 313 | 13 | N/A | 32 | N/A |
| 12/31/2014 | 134 | -1 | N/A | 16 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de ASTH ( 18.7% par an) est supérieure au taux d'épargne ( 2.5% ).
Bénéfices vs marché: Les bénéfices de ASTH ( 18.7% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).
Croissance élevée des bénéfices: Les bénéfices de ASTH devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de ASTH ( 16% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de ASTH ( 16% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de ASTH devrait être élevé dans 3 ans